This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1977-1979.
Company Filing History:
Years Active: 1977-1979
Title: Ursula Dahn: Innovator in Antibiotic Development
Introduction
Ursula Dahn is a notable inventor based in Filderstadt, Germany. She has made significant contributions to the field of antibiotic development, particularly through her work with the strain Streptomyces tendae Ettlinger. With a total of 2 patents, her innovations have the potential to impact the medical community significantly.
Latest Patents
Dahn's latest patents include a fungicidally active antibiotic derived from Streptomyces tendae Ettlinger. The new antibiotic, Nikkomycin, is produced by culturing the strain in a nutrient medium at a pH of about 5.5 to 8 under aerobic conditions. The isolation process involves cation exchange from the culture filtrate, followed by elution. This antibiotic is characterized by its structural formula and is noted for its fungicidal activity.
Career Highlights
Ursula Dahn is currently associated with Bayer Aktiengesellschaft, where she continues her research and development in antibiotics. Her work has been instrumental in advancing the understanding and application of fungicidal agents in medicine.
Collaborations
Dahn has collaborated with notable colleagues, including Hanspaul Hagenmaier and Helmut Hohne. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Ursula Dahn's contributions to antibiotic development exemplify the importance of innovation in healthcare. Her work not only enhances our understanding of antibiotics but also paves the way for future advancements in medical treatments.